MedTrace Logo

Metvix Daylight PDT in Actinic Keratosis

NCT02674048 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 406

Last updated 2021-02-17

No results posted yet for this study

Summary

Prospective non-interventional study conducted in Australia, Brazil, Mexico and Europe to evaluate clinical practice with Metvix Daylight PDT in the treatment of mild to moderate actinic keratosis of the face/scalp and to assess physician and patient satisfaction.

Conditions

  • Actinic Keratosis

Interventions

OTHER

Metvix

Sponsors & Collaborators

  • Parexel

    collaborator INDUSTRY

  • Galderma R&D

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-10-31
Completion
2016-11-30

Countries

  • Australia
  • France
  • Italy
  • Netherlands
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02674048 on ClinicalTrials.gov